Results 261 to 264 of about 368,793 (264)

Aumolertinib with carboplatin–pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open‐label, multicenter, randomized phase 3 study

Ca-A Cancer Journal for Clinicians
Da-Xing Zhu
exaly  

Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer

Oncogene, 2009
Federico Cappuzzo, Cappuzzo F
exaly  

EGFR-activated myofibroblasts promote metastasis of pancreatic cancer

Cancer Cell
Giulia Biffi, Muntadher Jihad, Joaquin Araos Henriquez   +2 more
exaly  

EGFR

openaire   +1 more source